Ekkehard Grünig

Risk assessment in pulmonary arterial hypertension

M. Humbert, S. Rosenkranz, O. Sitbon, 2018, European Respiratory Journal.

Phenotypes and treatment outcomes in idiopathic pulmonary arterial hypertension patients with comorbidities

Stephan Rosenkranz, Ekkehard Grünig, D. Skowasch, 2023, ERJ open research.

Randomized Trial of Macitentan/Tadalafil Single-Tablet Combination Therapy for Pulmonary Arterial Hypertension.

Ekkehard Grünig, P. Jansa, F. Fan, 2024, Journal of the American College of Cardiology.

Performance of DETECT PAH algorithm according to the hemodynamic definition of pulmonary arterial hypertension (PAH) in the 2022 ESC/ERS guidelines: Early detection of pulmonary arterial hypertension in systemic sclerosis patients.

M. Vonk, L. Di Scala, J. G. Coghlan, 2023, Arthritis & rheumatology.

The nitric oxide–soluble guanylate cyclase–cGMP pathway in pulmonary hypertension: from PDE5 to soluble guanylate cyclase

J. Stasch, Peter Sandner, Ekkehard Grünig, 2024, European Respiratory Review.

Pulmonary arterial hypertension-related myopathy: an overview of current data and future perspectives.

E. Bossone, A. Cittadini, E. Grünig, 2015, Nutrition, metabolism, and cardiovascular diseases : NMCD.